Gels

Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel

Retrieved on: 
Thursday, July 22, 2021
Gels, Colloidal chemistry, Hydrogel, Water chemistry, Natural sciences, Wound, Clinical medicine, Health sciences

WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class coactiv+ technology.

Key Points: 
  • WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class coactiv+ technology.
  • Use of the coactiv+TM technology in wound care products will complement the companys disruptive DispersinB wound care product development efforts whilst enabling the pursuit of the simpler 510(k) regulatory route and potentially quicker market access.
  • Kane estimates the US market for wound care hydrogels to be approximately US$200M.
  • We are committed to getting our coactiv+TM technology in the hands of wound care professionals and their patients as quickly as possible.

Terasaki Institute for Biomedical Innovation and Tetratherix™ Form Collaboration

Retrieved on: 
Tuesday, July 20, 2021
Physical sciences, Natural sciences, Biomaterials, Chemistry, Colloidal chemistry, Gels, Hydrogel, Water chemistry, Biocompatibility, Bio-ink, Draft:Terasaki Institute for Biomedical Innovation

LOS ANGELES, July 20, 2021 /PRNewswire/ -- The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with Tetratherix, a company which produces Tetramatrix, a synthetic injectable hydrogel currently being clinically tested in a variety of biomedical applications.

Key Points: 
  • LOS ANGELES, July 20, 2021 /PRNewswire/ -- The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with Tetratherix, a company which produces Tetramatrix, a synthetic injectable hydrogel currently being clinically tested in a variety of biomedical applications.
  • The unique and advantageous features of Tetramatrix offers the potential for further development into biocompatible, adhesive bioinks for deep tissue applications.
  • "This project will allow us to conduct world-class research in collaboration with TIBI to further expand our product pipeline in key therapeutic areas," said Ali Fathi, Tetratherix Founder and Director.
  • It is the hope that by optimizing the Tetramatrix bioinks, the TIBI researchers can help to translate them into viable biomedical applications.

Insights on the Sol-Gel Products Global Market to 2026 - Featuring 3M, CMR Coatings and Porcelain Industries Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021
Other Manufacturing, Manufacturing, Physical sciences, Chemistry, Natural sciences, Dosage forms, Thin film deposition, Gels, Ceramic engineering, Sol–gel process

Silica based sol-gel coatings represents huge potential to be implemented in optical devices, like optical sensors and active coatings.

Key Points: 
  • Silica based sol-gel coatings represents huge potential to be implemented in optical devices, like optical sensors and active coatings.
  • Hence, owing to the above-mentioned factors, the sol-gel coatings application is likely to dominate the forecast period during the forecast period.
  • North America accounts for the largest market share in the global sol-gel products market currently with the major demand coming from the united states.
  • In the United States, the growing demand for sol-gel coatings from the aerospace industry is driving the demand for sol-gel products.

Global Polyacrylamide Market Growth, Trends, COVID-19 Impact, and Forecasts 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 16, 2021
Chemicals, Plastics, Manufacturing, Acrylamides, Gels, Neurotoxins, Polyacrylamide, Polyelectrolytes, Compound annual growth rate, Chemistry, Academic disciplines, Matter

The "Polyacrylamide Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polyacrylamide Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • The polyacrylamide market is expected to register a CAGR of more than 5% during the forecast period.
  • The polyacrylamide market is highly consolidated, with the major players accounting for a major share of the market.
  • The company generated ~80% of it's net revenue from the polyacrylamide business, and accounted for 48% of the global market.

Global Hydrolyzed Collagen Market to 2027 - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, June 4, 2021
Fitness & Nutrition, Health, Structural proteins, Articles, Branches of biology, Food and drink, Dietary Supplements, Excipients, Gelatin, Gels, Collagen, Nutraceutical, Draft:Rousselot

Hydrolyzed collagen, also known as collagen hydrolysate, is made of short chains of amino acids derived from collagen.

Key Points: 
  • Hydrolyzed collagen, also known as collagen hydrolysate, is made of short chains of amino acids derived from collagen.
  • The pharmaceutical & nutraceuticals segment led the hydrolyzed collagen market with the highest market share in 2019.
  • In 2019, Europe held the largest share of the global hydrolyzed collagen market, followed by Asia Pacific.
  • Food & beverages is one of the major application industries of hydrolyzed collagen and the negative effects of COVID-19 has adversely affected the hydrolyzed collagen market.

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

Retrieved on: 
Wednesday, June 2, 2021
Stem cells, Biotechnology, Manufacturing, Diabetes, Health, General Health, Pharmaceutical, Oncology, Research, Engineering, Science, Colloidal chemistry, Gels, Hydrogel, Water chemistry, Accelerator, Harvard Office of Technology Development, Obatala Sciences, HARVARD OFFICE OF TECHNOLOGY DEVELOPMENT, OBATALA SCIENCES

Harvard Office of Technology Development and Obatala, which manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, announced the agreement today.

Key Points: 
  • Harvard Office of Technology Development and Obatala, which manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, announced the agreement today.
  • This ground-breaking technology provides a more accurate and dynamic model of human tissue in its diseased state compared to traditional two-dimensional culture.
  • The worldwide license agreement with Harvard enables Obatala to make the technology widely available for researchers use in drug discovery and R&D.
  • To further bridge the academic-industry development gap, Harvard OTD manages the Blavatnik Biomedical Accelerator and the Physical Sciences & Engineering Accelerator.

Polyacrylamide (CAS 9003-05-8) Global Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 1, 2021
Chemicals, Plastics, Manufacturing, Acrylamides, Gels, Neurotoxins, Polyacrylamide, Polyelectrolytes, Chemistry, Matter, Chemical substances

The "Polyacrylamide (CAS 9003-05-8) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polyacrylamide (CAS 9003-05-8) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Polyacrylamide.
  • The fifth chapter deals with Polyacrylamide market trends and forecast, distinguish Polyacrylamide manufacturers and suppliers.
  • The Polyacrylamide global market report key points:

UroGen Pharma Announces June 2021 Conference Schedule

Retrieved on: 
Tuesday, May 25, 2021
Biotechnology, Pharmaceutical, Health, Oncology, Health sciences, Life sciences, Pharmacology, Biotechnology, Pharmaceutical industry, Colloidal chemistry, Gels, Hydrogel, Water chemistry, Modified-release dosage, Urology, Biopharmaceutical

A replay of each webcast will be available on the website for approximately 30 days.

Key Points: 
  • A replay of each webcast will be available on the website for approximately 30 days.
  • UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options.
  • UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.
  • UroGen is headquartered in Princeton, NJ with operations in Israel.

Darling Ingredients' Rousselot Brand Launches GelDAT, First ever purified and phenol-functionalized gelatin

Retrieved on: 
Thursday, May 20, 2021
Food and drink, Structural proteins, Foods, Excipients, Animal products, Gels, Gelatin, Collagen, Rousselot, Draft:Rousselot

b'IRVING, Texas, May 20, 2021 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) today announced that its Rousselot brand, the global leader of collagen-based solutions, expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure GelDAT Gelatin Desaminotyrosine.

Key Points: 
  • b'IRVING, Texas, May 20, 2021 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR) today announced that its Rousselot brand, the global leader of collagen-based solutions, expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure GelDAT Gelatin Desaminotyrosine.
  • However, GelTYR has several limitations, most notably its irreproducibility and the lack of a scalable production process.
  • Rousselot Biomedical delivered a tailored X-Pure GelDAT solution, from customer\'s initial briefing into pre-clinical trials in less than a year!
  • "\nRousselot\'s proprietary, scalable process means products with customized functionalities can be produced in a standardized, purified, traceable and consistent manner.

Insights on the Carrageenan Global Market to 2028 - by Product, Function, Application and Regions - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 18, 2021
Retail, Natural Resources, Other Natural Resources, Food, Beverage, Food and drink, Foods, Food additives, Polysaccharides, Carrageenan, Microbicides, Gels, Thickening agent, Chondrus crispus, Gelatin dessert, Lion

b'The "Carrageenan Market Share, Size, Trends, Industry Analysis Report, By Product; By Function; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global carrageenan market size is expected to reach USD 1.18 billion by 2028 according to a new study.

Key Points: 
  • b'The "Carrageenan Market Share, Size, Trends, Industry Analysis Report, By Product; By Function; By Application; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global carrageenan market size is expected to reach USD 1.18 billion by 2028 according to a new study.
  • The growing demand for natural baked foods and the rising trend for healthy snacks is expected to drive the product demand.
  • Moreover, the growing use of carrageenan as a thickening and gelling agent in bakery products is also increasing the segment\'s market growth prospects.\nThe pharmaceutical market segment is project ted to hold revenue share.
  • Carrageenan is used as excipients in drug delivery systems as suspender, wetting agent, solubilizing agent, stabilizer, and adhesive agent.